SpaceX Quiet Period Ends: 22 Investment Bank Reports to Test $2 Trillion Valuation
N.R. Finch
The underwriter quiet period following SpaceX's $86 billion IPO lifts next Tuesday, with 22 banks set to publish research, price targets, and earnings forecasts — the market's first systematic sell-side test of a $2 trillion-plus company that has yet to turn a profit.
What has the stock done since listing?
SpaceX priced at $135, opened at $150 the next day, then surged to a close of $201.80 on June 16 — briefly hitting a $2.6 trillion market cap and becoming the world's sixth-largest company.
The rally reversed. By Wednesday the stock closed at $157.54, down roughly 22% from the peak, with market cap falling below $2.1 trillion.
This means → In barely a week, sentiment flipped from "chase the IPO pop" to "step back and reassess" — and the quiet-period lift lands right on that inflection.
Is the valuation actually expensive?
On a forward 12-month price-to-sales basis, SpaceX trades at 41× — above Palantir's 32×, the highest in the S&P 500, and far beyond Apple's and Microsoft's sub-9×.
In plain terms = investors are paying more than four times what they pay for each dollar of Apple's revenue.
The company is expected to generate roughly $36 billion in 2026 revenue and is not yet profitable. This reflects a market buying a vision of the future, not today's financials.
Why are Wall Street forecasts so far apart?
Goldman Sachs projects $474 billion in total revenue by 2030. Evercore ISI sees sales topping $1 trillion by 2031. Morgan Stanley reportedly estimates $3.4 trillion in revenue by 2040.
In plain terms = the gap between the most bullish and most conservative calls is several multiples wide, and the timelines stretch a decade or more — at that point it stops being analysis and starts being a bet.
Portfolio manager Vikram Rai quipped: "I might not be alive by then. When forecasts are pushed that far into the future, there is simply no way to verify them."
What are the bears worried about?
Morningstar rates SpaceX a sell. CFRA analyst Keith Snyder set a $115 target — below the $135 IPO price — citing elevated valuation and significant capital intensity.
Snyder wrote: "The current investment thesis requires investors to endorse multiple hard-to-deliver expectations simultaneously."
This means → The bear case is not that SpaceX is a bad company. It is that even a great company can be a poor investment if the price already assumes every future success.
Can the Nasdaq-100 inclusion support the stock?
SpaceX's addition to the Nasdaq-100 is expected to drive roughly $4.9 billion in passive buying, providing short-term price support.
But strategist Art Hogan cautioned: "Everyone is talking about where this company could be in 2030, not what it will deliver over the next 12 months."
This means → Passive inflows are a one-time buying force — they can prop up the price briefly, but they cannot answer whether the valuation holds long-term.
What does next week's research wave actually need to prove?
Published estimates suggest SpaceX could reach a slim profit by 2028, with revenue roughly quadrupling from current levels to about $160 billion.
Analyst George Ferguson's team noted that even if sales grow nearly 9× and EBITDA grows 17× by 2030, SpaceX's valuation would still exceed Microsoft, Meta, Google, and Amazon on their 2026 earnings.
Put simply = the 22 reports' real test is not how high a target price they set — it is whether they can anchor the $2 trillion valuation to something quantifiable in the near term. If they cannot, the market will keep swinging between conviction and fear.
Content is for reference only, not financial advice.